New Dermatologic Presentation Associated With SARS-CoV-2 Infection

JAMA Dermatology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, APRIL 7, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2021.0385?guestAccessKey=e0c3492a-59c9-414a-9dc0-e1c8060c0fb9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040721

 

What The Study Did: Researchers report on the observation of a newly associated mucocutaneous eruption in a pediatric patient with confirmed SARS-CoV-2 infection

Authors: Zachary E. Holcomb, M.D., of Boston Children’s Hospital, is the corresponding author.

 

(doi:10.1001/jamadermatol.2021.0385)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.